Skip to main content

Clinical Trials

Search among the clinical trials we have open at the Vall d'Hebron Research Institute.

Phase Title Sort descending Service Recruitment
Phase III A controlled, open-label post-authorisation efficacy and safety study in imlifidase… Nephrology Yes
Phase III A multicenter, open-label study to investigate the effectiveness and safety of AOP Landiolol… Pediatric Cardiology Yes
Phase III A multi-center, open-label, uncontrolled, single-arm, extension study to determine the… Internal Medicine Yes
Phase II A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Design,… Neurology No
Phase III A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group… Neurology Yes
Phase II A Multicentre Controlled Open Randomized Clinical Trial to evaluate the efficacy and… Infectious Yes
Phase II A MULTI-PART, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED PHASE 2 CLINICAL STUDY OF… Internal Medicine No
Phase II A phase 2, 24-week, adaptive, open label, sequential cohort trial to evaluate the… Nephrology Yes
Phase II A phase 2, multicenter, open-label study to assess appropriate dosing and to evaluate… Pediatric Oncohematology Yes
Phase II A Phase 2, Open-Label, Single-Arm Study of Pamiparib (BGB-290) for the Treatment of… Unclassified No
Phase II A Phase 2 Open-Label Study of Continuation Treatment With Combination Pyrimidine Nucleosides… General Pediatrics and Specialties Yes
Phase II A Phase 2, Randomized, Double-blind, Placebo-controlled, Multicenter, Dose-finding… Unclassified Yes
Phase II “A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy,… Neurology No
Phase II A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate theSafety, Efficacy,… Nephrology Yes
Phase III “A Phase 2/3, Multicenter, Randomized, Double-blind, Placebo controlled Trial of the… Psychiatry No
Phase III A phase 2/3, randomized, open-label, parallel group, 2-arm, multicenter study… Internal Medicine Yes
Phase III A Phase 2/3 Single-Arm, Open-Label Study to Evaluate the Safety, Tolerability,… General Pediatrics and Specialties Yes
Phase II A Phase 2a Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and… Pneumology Yes
Phase III A Phase 3, Multicenter, Randomized, Double-Blind, Placebo Controlled Study to Evaluate… Internal Medicine Yes
Phase III A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-445… Pneumology Yes
Phase III A Phase 3, Open-label Study Evaluating the Long-term Safety of VX-445 Combination… Obstetrics Yes
Phase III A Phase 3, Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate a Switch to… Infectious Yes
Phase III A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Ralinepag to Evaluate… Pneumology No
Phase III A Phase 3 Randomized, Open-Label, Multicenter Study Comparing Zanubrutinib (BGB-3111)… General Pediatrics and Specialties Yes